Step 1: Understanding anticholinesterase drugs. Anticholinesterase drugs inhibit the enzyme acetylcholinesterase, thereby increasing the levels of acetylcholine in the synaptic cleft. They are classified based on their duration of action into short-acting, intermediate-acting, and long-acting drugs.
Step 2: Characteristics of Edrophonium. Edrophonium is a short-acting anticholinesterase drug with a rapid onset and brief duration of action (around 10-20 minutes). It is primarily used in the diagnosis of myasthenia gravis due to its quick effect.
Step 3: Why other options are incorrect.
- (A) Physostigmine: Intermediate-acting anticholinesterase.
- (C) Ecothiophate: Long-acting anticholinesterase, used in the treatment of glaucoma.
- (D) Neostigmine: Intermediate-acting anticholinesterase, used in the treatment of myasthenia gravis and to reverse neuromuscular blockade.
Ingrediant | Function | Table A | Table B | Table C | Table D | ||
A | Aceta- minophen | I | Drug | 300 mg | - | 300 mg | 300 mg |
B | Aspirin | II | Drug | - | 300 mg | - | - |
C | Lactose | III | Filler | 100 mg | 100 mg | - | 100 mg |
D | Avicel | IV | Filler | - | - | 100 mg | - |
starch | Dis-integrant | 50 mg | 50 mg | - | 50 mg | ||
Avicel | Dis-integrant | - | - | 50 mg | - | ||
Magsterate | Lubricant | 2 mg | 2 mg | 2 mg | 2 mg | ||
Gelatin | Binder | 10 mg | 10 mg | 10 mg | 10 mg |
List I | List II | ||
---|---|---|---|
A | Grignard reagent | I | R2CuLi |
B | Gilman reagent | II | RMgX |
C | Benzyne mechanism | III | 2 molecules of CH3CHO |
D | Aldol condensation | IV | SNAr |